Clinical Trials in Austin

Showing 8321-8340 of 15,205 trials

Telehealth Depression Treatments for Older Adults

NCT02600754

This study aims to find an effective and sustainable approach to reducing disparities in accessing mental health services for an underserved and growing population group of low-income, racially diverse, homebound older adults. It will compare two aging-service integrated, teledelivered depression treatments for these seniors. One model is short-term problem-solving therapy by licensed clinicians; the second model is self-care management support by trained lay advisors. The findings are expected to create a foundation of information for guiding the implementation of acceptable, effective, and sustainable depression care within widely available aging-service infrastructures.

Depression

University of Texas at Austin277 participantsStarted Feb 2016

Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

NCT03861936

Based on the results of the Phase 2 Study 191622-130 \[NCT02010775\], the current Phase 2b study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of Masseter Muscle Prominence (MMP) in adults.

Masseter Muscle Prominence

Allergan150 participantsStarted May 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

Telehealth Depression Treatments for Older Adults

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Find Trials by Condition in Austin

Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Post Approval Study of the remedē System

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Global Anticoagulant Registry in the Field

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Corneal Collagen Cross-Linking for Ectasia (CXL)

Heart Sounds Registry

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event